$271 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 62 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 55.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CELG | Buy | Celgene Corp | $22,214,000 | +95.5% | 235,522 | +4.4% | 8.21% | +16.4% |
GILD | Buy | Gilead Sciences Inc | $18,094,000 | +72.6% | 278,284 | +30.5% | 6.68% | +2.8% |
REGN | Buy | Regeneron Pharmaceuticals | $12,985,000 | +41.3% | 31,630 | +1.0% | 4.80% | -15.9% |
STML | Buy | Stemline Therapeutics Inc | $10,232,000 | +134.4% | 796,245 | +35.9% | 3.78% | +39.5% |
ALXN | Alexion Pharmaceuticals Inc | $9,952,000 | +76.7% | 73,641 | 0.0% | 3.68% | +5.2% | |
VRTX | Sell | Vertex Pharmaceuticals Inc | $9,400,000 | -19.8% | 51,122 | -43.3% | 3.47% | -52.3% |
NBIX | Sell | Neurocrine Biosciences Inc | $9,128,000 | +29.4% | 103,600 | -17.6% | 3.37% | -23.0% |
PTCT | New | PTC Therapuetics COM | $9,050,000 | – | 240,493 | +100.0% | 3.34% | – |
INCY | Sell | Incyte Corp | $8,728,000 | -31.3% | 101,500 | -60.1% | 3.22% | -59.1% |
ALKS | New | ALKERMES PLC | $8,502,000 | – | 233,000 | +100.0% | 3.14% | – |
ILMN | Sell | ILLUMINA INC | $7,799,000 | -1.5% | 25,100 | -25.3% | 2.88% | -41.3% |
HALO | Buy | Halozyme Therapeutics Inc | $7,658,000 | +67.2% | 475,633 | +19.3% | 2.83% | -0.5% |
ACAD | Sell | ACADIA PHARMACEUTICALS INC | $7,220,000 | +101.7% | 269,000 | -4.6% | 2.67% | +20.1% |
AERI | Buy | Aerie Pharmaceuticals Inc | $7,178,000 | +1588.9% | 151,117 | +907.4% | 2.65% | +904.5% |
KALV | Sell | Kalvista Pharmaceuticals Inc | $6,062,000 | +22.4% | 213,061 | -33.3% | 2.24% | -27.1% |
ENTA | Buy | Enanta Pharmaceuticals Inc | $5,827,000 | +143.8% | 61,000 | +41.9% | 2.15% | +45.2% |
EXEL | Sell | Exelixis Inc | $5,794,000 | -36.4% | 243,534 | -58.7% | 2.14% | -62.1% |
BMRN | Sell | Biomarin Pharmaceutical Inc | $5,704,000 | -7.6% | 64,284 | -30.3% | 2.11% | -45.0% |
WVE | New | WAVE LIFE SCIENCES LTD | $5,632,000 | – | 145,000 | +100.0% | 2.08% | – |
SAGE | Buy | Sage Therapeutics Inc | $5,407,000 | +349.5% | 33,996 | +112.5% | 2.00% | +167.5% |
ZGNX | Zogenix Inc | $5,114,000 | +92.3% | 93,000 | 0.0% | 1.89% | +14.5% | |
RTRX | New | Retrophin Inc | $4,703,000 | – | 208,000 | +100.0% | 1.74% | – |
AMGN | Amgen Inc | $4,558,000 | +24.2% | 24,000 | 0.0% | 1.68% | -26.0% | |
SGEN | Buy | Seattle Genetics Inc | $4,460,000 | +136.0% | 60,900 | +43.3% | 1.65% | +40.5% |
IONS | Buy | Ionis Pharmaceuticals Inc | $3,877,000 | +128.3% | 47,781 | +19.5% | 1.43% | +35.9% |
HZNP | Buy | Horizon Pharma Plc | $3,382,000 | +219.4% | 128,000 | +85.5% | 1.25% | +90.1% |
ABMD | Abiomed Inc | $3,341,000 | +11.9% | 11,700 | 0.0% | 1.23% | -33.4% | |
INSM | New | INSMED INC | $3,198,000 | – | 110,000 | +100.0% | 1.18% | – |
ALNY | Alnylam Pharmaceuticals Inc | $3,160,000 | +63.3% | 33,800 | 0.0% | 1.17% | -2.8% | |
SUPN | Buy | Supernus Pharmaceuticals Inc | $3,150,000 | +475.9% | 89,953 | +329.3% | 1.16% | +243.4% |
XENT | Intersect Ent Inc | $3,087,000 | +45.4% | 96,000 | 0.0% | 1.14% | -13.4% | |
AMRN | Buy | Amarin Corp Plcspons adr new | $2,841,000 | +232.7% | 137,000 | +71.2% | 1.05% | +98.1% |
GWPH | Buy | GW Pharmaceuticals Plcads | $2,831,000 | +286.7% | 16,800 | +75.0% | 1.05% | +130.4% |
BLUE | Bluebird Bio Inc | $2,675,000 | +102.0% | 17,000 | 0.0% | 0.99% | +20.2% | |
AGIO | Agios Pharmaceuticals Inc | $2,462,000 | +86.4% | 36,500 | 0.0% | 0.91% | +11.0% | |
BIIB | Sell | Biogen Inc | $2,245,000 | -44.7% | 9,500 | -44.8% | 0.83% | -67.1% |
AKCA | New | AKCEA THERAPEUTICS INC | $2,110,000 | – | 74,608 | +100.0% | 0.78% | – |
RDUS | Sell | Radius Health Inc | $2,109,000 | -38.3% | 105,829 | -59.9% | 0.78% | -63.3% |
NKTR | NEKTAR THERAPEUTICS | $2,016,000 | +30.2% | 60,000 | 0.0% | 0.74% | -22.5% | |
ARRY | Array Biopharma Inc | $1,767,000 | +117.9% | 72,500 | 0.0% | 0.65% | +29.8% | |
STRO | SUTRO BIOPHARMA INC | $1,670,000 | +58.7% | 146,653 | 0.0% | 0.62% | -5.5% | |
SRPT | Sell | Sarepta Therapeutics Inc | $1,643,000 | +12.8% | 13,800 | -18.8% | 0.61% | -32.9% |
GTHX | New | G1 Therapeutics Inc | $1,631,000 | – | 98,482 | +100.0% | 0.60% | – |
ASND | New | ASCENDIS PHARMA A Ssponsored adr | $1,624,000 | – | 13,800 | +100.0% | 0.60% | – |
MRTX | New | MIRATI THERAPEUTICS INC | $1,590,000 | – | 21,700 | +100.0% | 0.59% | – |
MYOK | New | Myokardia INC | $1,559,000 | – | 30,000 | +100.0% | 0.58% | – |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,544,000 | – | 30,000 | +100.0% | 0.57% | – |
GBT | New | Global Blood Therapeutics | $1,481,000 | – | 28,000 | +100.0% | 0.55% | – |
XLRN | New | ACCELERON PHARMA INC | $1,396,000 | – | 30,000 | +100.0% | 0.52% | – |
MYGN | New | Myriad Genetics inc | $1,273,000 | – | 38,365 | +100.0% | 0.47% | – |
IFRX | New | INFLARX NV | $1,223,000 | – | 32,500 | +100.0% | 0.45% | – |
GMED | Globus Med Inc | $1,196,000 | +45.5% | 24,200 | 0.0% | 0.44% | -13.3% | |
FGEN | FibroGen Inc | $1,071,000 | +49.6% | 19,700 | 0.0% | 0.40% | -10.8% | |
MLND | New | Millendo Therapeutics Inc | $925,000 | – | 61,860 | +100.0% | 0.34% | – |
LGND | Sell | Ligand Pharmaceuticals Inc | $918,000 | -84.7% | 7,300 | -87.0% | 0.34% | -90.9% |
FOLD | Amicus Therapeutics Inc | $796,000 | +80.9% | 58,600 | 0.0% | 0.29% | +7.7% | |
MNTA | New | MOMENTA PHARMACEUTICALS INC | $792,000 | – | 54,580 | +100.0% | 0.29% | – |
TCDA | New | Tricida Inc | $751,000 | – | 19,066 | +100.0% | 0.28% | – |
ARNA | New | Arena Pharmaceuticals Inc | $740,000 | – | 16,500 | +100.0% | 0.27% | – |
SGMO | Sangamo Therapeutics Inc | $457,000 | +5.8% | 48,000 | 0.0% | 0.17% | -36.9% | |
DERM | New | Dermira Inc | $407,000 | – | 30,000 | +100.0% | 0.15% | – |
MGNX | New | MACROGENICS INC | $342,000 | – | 19,000 | +100.0% | 0.13% | – |
PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -24,000 | -100.0% | -0.23% | – |
ONCE | Exit | Spark Therapeutics Inc | $0 | – | -12,000 | -100.0% | -0.23% | – |
SBPH | Exit | Spring Bk Pharmaceuticals Inc | $0 | – | -73,000 | -100.0% | -0.37% | – |
SHPG | Exit | Shire plcsponsored adr | $0 | – | -25,000 | -100.0% | -2.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
AMGEN INC COM | 25 | Q3 2023 | 7.9% |
NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-18 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-20 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.